CAS 54965-24-1 Tamoxifen Citrate Nolvadex Powder C26H29NO.C6H8O7 Molecular Formula

Quick Details:

Product name: Tamoxifen Citrate

Alias: Tamoxifen,Nolvadex,STERANABOL;TURINABOL,kessar; noltam; tamofen

CAS Registry Number: 54965-24-1

EINECS: 259-415-2

Assay: 99%

Molecular Formula: C26H29NO.C6H8O7

Molecular weight: 563.64

MP: 140-144 oC

Appearance: white crystalline powder

Other drugs in same class: Anastrozole,Letrozole,Tamoxifen citrate,Exemestane

Usage: the goods to anti-estrogen fertility inducer, the objects in

dysfunctional uterine bleeding, polycystic ovary, menstrual disorders and drug-

induced amenorrhea and other gynecologic diseases;It is used as a first line

defense against breast cancer.

What is Tamoxifen Citrate (Nolvadex) ? 

Nolvadex, officially known as Tamoxifen Citrate, was first developed in 1961 by ICI now AstraZeneca under the trade name Nolvadex.

However, it has also been effectively used in breast cancer prevention. Then we have anabolic steroid users, and it was long ago discovered that Nolvadex had a place among such individuals.

The SERM was developed to treat breast cancer, specifically hormone-responsive breast cancer.

It is also used as part of a Post Cycle Therapy (PCT) recovery plan, which is its most common and beneficial point of use for the steroid user.

Application:

Tamoxifen slows or stops the growth of cancer cells that are already present in

the body. It also reduces the risk of breast cancer in women who have a high risk for this disease. It helps keep the original breast cancer from coming back and helps prevent new cancer in the opposite breast. Tamoxifen is used to prevent and treat breast cancers that test positive for estrogen receptors

(ER+).

It is often called an "anti- estrogen."For postmenopausal women, a two-stage treatment using tamoxifen and then an aromatase inhibitor, such as anastrozole (Arimidex), exemestane (Aromasin), or letrozole (Femara) may work better than only taking tamoxifen. It blocks the effects that the hormone estrogen has on cancer cells and lowers the chance that breast cancer will grow.

Tamoxifen is highly effective in lowering the risk of breast cancer recurrence.

In women who have already had breast cancer, tamoxifen also lowers the risk of

breast cancer in the opposite breast (contralateral).

Tamoxifen Citrate (Nolvadex) cycle or dose reviews

For the purpose of estrogenic side effect protection during anabolic steroid use, 10-20mg per day is common. If 20mg per day does not protect you from gynecomastia you will need an Aromatase Inhibitor.

For the purpose of PCT, standard Nolvadex doses will normally begin at 40mg per day. If HCG is included, this will also affect the timing. The dose will normally hold at 40mg per day for a couple weeks, reduce to 20mg per day for a couple weeks and then finish with an optional week or two at 10mg per day. How your cycle ends will determine when you begin your Nolvadex therapy.

If your cycle ends with all small ester base anabolic steroids, you will begin your Nolvadex 3 days after your last injection.

If your cycle ends with all small ester base anabolic steroids, you will begin HCG 3 days after your last injection and begin Nolvadex after HCG therapy is complete.

Our Services for you